MYD88 and Hepatic fibrosis: Additionally, BSP exhibits the ability to alleviate hepatic fibrosis through the TLR2/TLR4-MyD88-NF-κB signaling pathway, ultimately achieving hepatic protection (Jiang et al., 2023).